Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

The Journal of Nutritional Biochemistry, 2026
Replacing red meat with non-soy legumes alters choline metabolites but not systemic inflammation or proxies of gut barrier function in healthy males in a 6-week RCT

Pietilä T., Cantini E., Itkonen S. et al.

Olink Target 96Nutritional SciencePathophysiologyPlasma

Journal of Lipid Research, 2026
Low serum sphingosine-1-phospate and its chaperone ApoM associate with retinopathy of prematurity

Nilsson A., Sjöbom U., Panwar M. et al.

Olink Target 96OphthalmologyObstericsPathophysiologySerum

Diabetes, Obesity and Metabolism, 2026
Proteomic Profiling of Plasma to Uncover Novel Intervention Targets and Prognostic Biomarkers for Chronic Liver Diseases

Li X., Sun J., Zhao J. et al.

Olink Explore 3072/384HepatologyCross-platform ValidationPlasma

Biomarker Research, 2026
Reprogramming myeloid cells and restoring T cell fitness in checkpoint inhibitor resistant melanoma patients

Grauers Wiktorin H., Ekström-Rydén V., Ek I. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Neuron, 2026
Sex-specific APOE4-dependent innate immunity regulates meningeal lymphatics, brain lipids, neuroinflammation, and cognition

Delivanoglou N., Todd K., Almeida F. et al.

Olink Target 48 MouseNeurologyPathophysiologyMouse Tissue Lysate

Nutrition & Metabolism, 2026
Proteomic signatures of life’s essential 8 and incident atrial fibrillation among individuals with chronic kidney disease

Wan Z., Zhou J., Han M. et al.

Olink Explore 3072/384CVDNephrologyPathophysiologyPlasma

Bioengineering, 2026
Machine-Learning-Based Targeted Plasma Proteomic Analysis for Predicting Motor Progression in Parkinson’s Disease: An Interpretable Approach to Personalized Disease Management

Lin W., Grewal S.

Olink Target 96NeurologyPatient StratificationPlasma

Human Reproduction, 2026
Large-scale analysis of FMR1 CGG repeat length and risk of premature ovarian insufficiency in over 92 000 women

Morbey E., Day F., Wright D. et al.

Olink Explore 3072/384GynecologyPathophysiologyPlasma

Rheumatology, 2026
Humoral responses against high-density lipoprotein are linked to unfavourable lipid and proteomic signatures in primary Sjögren’s disease—a multi-platform approach

Suárez-Díaz S., Miranda-Prieto D., López P. et al.

Olink Target 96Immunological & Inflammatory DiseasesCVDPathophysiologySerum

International Journal of Immunopathology and Pharmacology, 2026
Mendelian randomization implicates circulating plasma proteins in gout risk and identifies candidate therapeutic targets

Zhang H., Dang Z., Yu P. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma

Neurology Neuroimmunology & Neuroinflammation, 2026
CSF Proteins Associated With Neuroaxonal Damage in Early Active Multiple Sclerosis

Luessi F., Starvaggi Cucuzza C., Engel S. et al.

Olink Target 96Olink Explore 3072/384NeurologyPathophysiologySerumCSF

Journal of Hazardous Materials Advances, 2026
Plasma proteomic signatures link environmental exposures to lung cancer risk

Zhu Y., Wu Y., Tang Y. et al.

Olink Explore 3072/384OncologyEnvironmental Health & ToxicologyPathophysiologyPlasma

Communications Medicine, 2026
Adhesion molecules provide an endothelial protein signature in preclinical and clinical Alzheimer’s disease and predict clinical progression

Hajjar I., Neal R., Singh N. et al.

Olink Target 96NeurologyPathophysiologyPlasmaCSF

European Journal of Preventive Cardiology, 2026
Cardiovascular health across childhood and adolescence and proteomic biomarkers in late adolescence

Lin Z., Rifas-Shiman S., de Ferranti S. et al.

Olink Target 96CVDPatient StratificationPlasma

Global Insights in Medicine and Nursing, 2026
Bidirectional Mendelian Randomization Reveals IL-17C as a Protective Factor and Sepsis-Induced Inflammatory Protein Dynamics

Wang J., Chen Z., Zhang Y. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma

npj Cardiovascular Health, 2026
Berberine signature and cardiometabolic diseases using randomized controlled trial, cohort study and Mendelian randomization

Zhao J., Sarsani V., Chen B. et al.

Olink Target 96Metabolic DiseasesCVDPathophysiologyPlasma

Journal of Allergy and Clinical Immunology: Global, 2026
Impact of gut microbiome, plasma metabolites, peripheral immune cells, and circulating inflammatory protein on chronic spontaneous urticaria: Bidirectional 2-sample Mendelian randomization study and mediation analysis

Deng L., Yao Y., Wang Q. et al.

Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologyPlasma

Age and Ageing, 2026
Prostate ageing across the adult lifespan: population MRI evidence from 30 000 men

Kordes G., Schwarzkopf V., Ogoniak L. et al.

Olink Explore 3072/384UrologyAgingPathophysiologyPlasma

Vaccine, 2026
Neutralizing antibody titers do not predict T cell response to live-attenuated orthoflaviviral vaccination in humans

Ooi J., Hamis N., Tan H. et al.

Olink Target 48Immunological & Inflammatory DiseasesPathophysiologyPlasma

Metabolism, 2026
Large-scale plasma proteomics for predicting future cardiovascular and all-cause mortality among individuals with cardiovascular-kidney-metabolic syndrome stage 0–3

Weng B., Wei J., Chen H. et al.

Olink Explore 3072/384CVDNephrologyMetabolic DiseasesPatient StratificationPlasma

4146 publications